Halloran Consulting

What Halloran Consulting does

Halloran Consulting Group, Inc. is a privately held life science consulting firm founded in 1998 and headquartered in Cambridge, Massachusetts, with additional offices in San Diego and Boston. The firm provides integrated consulting services across the full drug and product development lifecycle, organized into five service phases: Discovery, Preclinical, Clinical Development, Commercialization, and All Stages. Core offerings include regulatory affairs (IND/NDA/BLA preparation, eCTD submissions, FDA meeting strategy, special designations), clinical operations (trial leadership, medical writing, program management), GxP quality management system development, and strategic advisory including biopharma due diligence and CDMO/CRO selection.

Halloran serves primarily early- and mid-stage biotech companies, with secondary exposure to MedTech and pharmaceutical clients. The firm does not develop proprietary technology products; its value is delivered through senior consulting professionals with deep FDA engagement experience spanning CDER, CBER, and CDRH divisions. The firm's stated track record includes thousands of regulatory submissions handled over more than two decades. Revenue is generated through project-based consulting engagements with quote-based pricing tied to scope, duration, and team composition—no public pricing tiers or SaaS/productized offerings are disclosed.

The go-to-market model is direct B2B sales supported by thought-leadership content (insights blog, webinars), proprietary industry events (CORE, Breadth in Bioscience Symposium), and participation in sector conferences. Customer acquisition relies on relationship-driven BD, website contact forms, and referral networks within the life sciences ecosystem. Halloran is founder-led (Laurie Halloran) and operates as an independent, privately held corporation (Halloran Consulting Group, Inc., domiciled in Massachusetts) with no disclosed institutional investors, funding rounds, M&A activity, or parent company.

Name

Halloran Consulting

Legal name

Halloran Consulting Group, Inc.

Website

https://hallorancg.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

51–100 employees

Short description

Halloran Consulting Group is a privately held life science consulting firm serving biotech, MedTech, and pharma clients with integrated regulatory, clinical development, quality management, and commercialization advisory services across the full product development lifecycle, from discovery through market launch.

Ownership category

akta.pro rank

Product category

Life Science Consulting

NAICS

Management Consulting Services (54161)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Strategy & Corporate Development Consulting (BPAHACAA)

akta.pro secondary industry

Operations & Process Improvement Consulting (BPAHACAB)

Keywords

• Life science consulting
• Regulatory affairs consulting
• Clinical development consulting
• Quality management systems
• Medical device regulatory

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Regulatory & Compliance Consulting Services: Halloran generates revenue through project-based consulting engagements across all phases of drug and product development, including regulatory affairs, clinical development, quality management, and commercialization support. Services are tailored to biotech, MedTech, and pharmaceutical companies from early discovery through market launch. Engagements range from strategic advising and regulatory submissions to clinical trial leadership, role-based staffing, and inspection readiness.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Halloran Consulting Group is a life science consulting firm that provides regulatory affairs, clinical operations, quality management, and strategic advisory services to biotech, MedTech, and pharmaceutical companies. Services are organized into five phases—Discovery, Preclinical, Clinical Development, Commercialization, and All Stages—spanning the full product development lifecycle from early discovery through market launch and post-approval compliance.

Product overview

Halloran Consulting Group is a life science consulting firm that offers a comprehensive suite of consulting services organized into five service phases: Discovery Phase Services, Preclinical Phase Services, Clinical Development Phase Services, Commercialization Phase Services, and All Stages Services. Their integrated development approach spans from early drug discovery through commercialization, providing strategic advising, regulatory guidance, quality management, clinical operations, and program leadership. The company serves biotech, MedTech, and pharmaceutical companies seeking to bring drugs, devices, and therapies to market.

Differentiator

Problem solved

Functional benefit

Products and services

• Discovery Phase Services Consulting services to help biotech, medical device, and pharmaceutical companies streamline discovery processes and improve pathways to regulatory and commercial launch, including indication assessment, landscape analysis, and strategic advising.
• Preclinical Phase Services Consulting services to help life science companies navigate preclinical testing, including clinical development planning, health authority meeting support, integrated development plans, regulatory IND readiness, GxP QMS development, and CDMO vendor selection.
• Clinical Development Phase Services Comprehensive consulting support for advancing through clinical development and health authority review, including IND applications, clinical trial leadership, medical writing, GxP quality assessment, regulatory operations, marketing applications, and inspection readiness.
• Commercialization Phase Services Consulting services to support post-approval stage including organizational design and transformation, GxP quality assessment and remediation, and regulatory CMC support to bring products to market and manage ongoing compliance.
• All Stages Services End-to-end consulting services covering strategic advising, audits and oversight, biopharma due diligence, program leadership and management, technology enablement, CRO/CDMO selection, and special designation assessment for companies at any development stage.

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Emerging players

• Pro-ficiency (Pro-ficiency Clinical & Regulatory Solutions): Pro-ficiency provides clinical trial training, simulation, and regulatory consulting services to pharma and biotech. Comparable as a specialized life sciences services firm helping clients navigate FDA interactions and clinical operations, though with a stronger technology-enabled training angle.
• Lindus Health / Experienced CROs for Biotech: Smaller specialty CROs and quality/regulatory boutiques (e.g., BioPlus Consulting, Azzur Group) compete with Halloran for biotech engagements in QMS, validation, and FDA inspection readiness. They overlap in target customer (early-stage biotech) and service type (quality and regulatory consulting).

Direct peers

• NDA Partners: NDA Partners is a regulatory and drug development consulting firm serving pharma and biotech clients. Directly comparable to Halloran in providing FDA strategy, NDA/BLA preparation, and senior regulatory advisor engagements for life science companies.
• Putnam Associates: Putnam Associates provides strategy consulting to biopharmaceutical, medical device, and diagnostics clients on pricing, market access, and product strategy. Comparable as a specialized life sciences strategy consultancy serving similar biotech and MedTech buyers.
• Camargo Pharmaceutical Services: Camargo Pharmaceutical Services is a regulatory strategy and drug development consulting firm serving biotech and pharma, with deep experience in 505(b)(2), ANDA, and NDA pathways. Closely comparable to Halloran's regulatory affairs and clinical development services.
• Health Advances: Health Advances is a strategy consulting firm exclusively focused on life sciences, advising biotech, MedTech, and diagnostics companies on corporate strategy, market access, and product development. Highly comparable in target market and B2B life science advisory model.
• Defined Health (a Panzura Group company): Defined Health is a strategy consulting firm focused exclusively on the life sciences industry, advising biotech and pharma clients on business development, therapeutic strategy, and corporate transactions. Comparable as a specialized life sciences strategy consultancy with similar client profile.

Broad incumbents

• Parexel (Consulting & Regulatory): Parexel is a major global CRO with a regulatory and clinical consulting practice serving pharma and biotech across all development phases. Comparable in service scope (regulatory, clinical, quality) but operates at significantly larger scale with full-service CRO delivery.
• Charles River Associates (Life Sciences Practice): Charles River Associates is a broad management consulting firm with a sizeable life sciences practice serving pharma, biotech, and MedTech clients. Comparable target customer base but offers services as part of a wider industry portfolio rather than specializing exclusively in life sciences regulatory/clinical.
• IQVIA (Consulting & Regulatory Services): IQVIA is the largest CRO and life science technology/consulting platform, offering regulatory affairs, clinical, and quality consulting as part of a broader portfolio. Overlaps with Halloran's regulatory and clinical advisory offerings but at much greater scale and with technology and data differentiators.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/HalloranConsult
• Facebookfacebook.com/halloranconsult
• LinkedInlinkedin.com/company/halloran-consulting-group-inc-

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Halloran Consulting